Submitted by Anonymous (not verified) on 13 September 2024 - 8:24
Opinion/decision on a Paediatric investigation plan (PIP): Namuscla, Mexiletine hydrochloride, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0300/2023
Source: